The Latest Cardiac and Vascular News
Dr. Laura Mauri will drive integration of medical and scientific intelligence and patient safety and engagement as chief scientific, medical and regulatory officer DUBLIN, April 25, 2022 /PRNewswire/ — Medtronic plc (NYSE:MDT) today announced that Laura Mauri, M.D., M.S.c. has been appointed Medtronic Chief Scientific, Medical and Regulatory Officer. This appointment adds to Dr. Mauri’s […]
DANVERS, Mass.–(BUSINESS WIRE)–Abiomed (Nasdaq: ABMD) announces the first patient in the world has been successfully implanted with Impella Bridge-to-Recovery (BTR) as part of the heart pump’s U.S. Food and Drug Administration (FDA) Early Feasibility Study (EFS). The first implant was done by Duc Thinh Pham, MD, and Jane Wilcox, MD, at […]
DiA’s AI-based software optimized with the Intel Distribution of OpenVINO toolkit enhances cardiologists’ decision-making process and workflow BE’ER SHEVA, Israel, April 26, 2022 /PRNewswire/ — DiA Imaging Analysis Ltd, a leading global provider of AI-powered ultrasound analysis software, has teamed up with Intel to streamline artificial intelligence (AI) solutions used by echocardiography (Echo) labs. DiA’s AI-based software, LVivo Seamless™, […]
tenacio announces the publication of “Universal Clinician Device for improving risk prediction and management of patients with atrial fibrillation. An assumed benefit analysis” in the European Heart Journal Digital Health The in-silico study demonstrated expected outcome benefits of 23% reduction in mortality, 24% reduction in strokes and 14% in bleeding […]
LAKE OSWEGO, Ore., April 26, 2022 /PRNewswire/ — BIOTRONIK, Inc. announced today it has received U.S. Food and Drug Administration (FDA) approval of Renamic Neo, the company’s state-of-the-art programmer for implanted cardiac rhythm management devices such as ICDs, pacemakers, and implantable cardiac monitors. In addition to its programming functions, Renamic Neo now […]
University of Vermont Medical Center Initiates Evaluation of the ECGenius System as CathVision Prepares for U.S. Launch COPENHAGEN, Denmark, April 26, 2022 /PRNewswire/ — CathVision, a medical technology company developing innovative electrophysiology solutions designed to guide and enhance cardiac ablation therapy through the acquisition of low-noise, high-fidelity electrograms, today announced the completion of patient […]
Access Vascular’s biomaterial catheters recognized as Best New Product in Science & Medical category for their ability to dramatically improve vascular access procedures and outcomes BILLERICA, Mass., April 26, 2022 (GLOBE NEWSWIRE) — Access Vascular, Inc. (AVI) today announced its biomaterial-based hydrophilic catheters received a Gold Award as the 2022 Edison […]
CCM Therapy Addresses an Unmet Clinical Need and Offers Hope to Millions With Heart Failure MARLTON, N.J., April 26, 2022 (GLOBE NEWSWIRE) — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), is proud to announce a worldwide milestone achievement as […]
First Quarter 2022 Revenue of $4.1 million, a 43% Increase Over Prior Year MINNEAPOLIS, April 25, 2022 (GLOBE NEWSWIRE) — CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced its financial and operating […]
Launch of capital increase of approximately €15 million for institutional investors with cancellation of the pre-emptive subscription right A minimum of €12 million subscription commitments received from institutional investors, including €10 million from Otium Capital Raise to coincide with pharmaceutical company Julphar acquiring stake in Quantum Genomics via reserved capital […]
